B

Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315

Watchlist Manager
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Watchlist
Price: 5.6 HKD -2.78% Market Closed
Market Cap: 2.2B HKD
Have any thoughts about
Biocytogen Pharmaceuticals Beijing Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Biocytogen Pharmaceuticals Beijing Co Ltd

Revenue
800.6m CNY
Cost of Revenue
-224.4m CNY
Gross Profit
576.2m CNY
Operating Expenses
-715.9m CNY
Operating Income
-139.8m CNY
Other Expenses
-104.1m CNY
Net Income
-243.8m CNY

Income Statement
Biocytogen Pharmaceuticals Beijing Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
632
N/A
717
+14%
801
+12%
Gross Profit
Cost of Revenue
(171)
(211)
(224)
Gross Profit
460
N/A
506
+10%
576
+14%
Operating Income
Operating Expenses
(935)
(812)
(716)
Selling, General & Administrative
(329)
(349)
(347)
Research & Development
(619)
(474)
(388)
Other Operating Expenses
14
11
19
Operating Income
(474)
N/A
(306)
+35%
(140)
+54%
Pre-Tax Income
Interest Income Expense
23
(14)
(43)
Non-Reccuring Items
(6)
16
22
Total Other Income
(61)
(76)
(77)
Pre-Tax Income
(518)
N/A
(380)
+27%
(238)
+37%
Net Income
Tax Provision
(1)
(3)
(6)
Income from Continuing Operations
(519)
(383)
(244)
Income to Minority Interest
0
0
0
Net Income (Common)
(519)
N/A
(383)
+26%
(244)
+36%
EPS (Diluted)
-1.3
N/A
-0.96
+26%
-0.61
+36%

See Also

Discover More